Floreo develops virtual-reality-based therapeutic experiences designed to help people with autism build social and communication skills within controlled immersive environments. The company is advancing its platform through an FDA review process and is using recent capital to continue product development while awaiting regulatory clearance. It received a $1 million investment from Cleveland Clinic Ventures, which the company says will support further technology development. Floreo plans to initiate a Series B financing round to secure additional funds for growth and expansion. The article does not report revenue, user counts, or other operating metrics. No founding year or location was provided in the article.

Total raised

$13M

Funding rounds

3

Latest round

Equity

Latest activity

Apr 2026